Skip to main content

Dr. Saira Sheikh is Elected to American College of Rheumatology (ACR’s) Board of Directors

December 2, 2022

In addition to joining the ACR’s governing body, Dr. Sheikh has been appointed to serve as the ACR Board of Directors liaison to the Collaborative Initiatives Department (COIN). The COIN department highlights rheumatology’s relevance to the healthcare community and public by using rheumatic diseases as case studies for treating complex disease, advancing health equity, eliminating … Continued

Using Collaboration to Fight a Tricky Tick-Borne Disease

November 22, 2022

Alpha-Gal Syndrome, or AGS, is a recently identified tick-borne disease that triggers an allergy to red meat and other products made from mammals, including cheese, gelatin, and medications like heparin. Since its discovery in 2009, cases in the United States alone have risen from 24 to >40,000 people, owing to the geographic spread of the … Continued

Dr. Mildred Kwan and Dr. Andrew Winslow Receive $100K Pfizer Grant to Address Health Disparities in Antimicrobial Stewardship

November 8, 2022

The 2-year grant will help build capacity to address health disparities through antimicrobial stewardship telehealth and telemonitoring. The name of the grant is: “A novel patient-led penicillin allergy de-labeling program targeting underserved children through a mobile-enabled virtual platform.” Dr. Kwan is an Allergy & Immunology faculty member in the UNC Thurston Arthritis Research Center, and … Continued

Drs. Phanstiel and Loeser Receive $2.5M NIH NIAMS Grant to ID Osteoarthritis Risk Genes

September 20, 2022

Dr. Richard F. Loeser is the Joseph P. Archie, Jr. Eminent Professor of Medicine in the Division of Rheumatology, Allergy and Immunology. Dr. Doug Phanstiel – who is in the Department of Cell Biology and Physiology – is the principal investigator, and Dr. Loeser is a co-principal investigator for the National Institute of Arthritis and Musculoskeletal and … Continued

Allen Receives 2-Year NIAMS Grant

January 21, 2022

Kelli Allen, PhD, professor of medicine in the division of rheumatology, allergy, and immunology, received a grant for a project titled “Optimizing Osteoarthritis Care Through Clinical & Community Partnerships.” The project addresses a critical need to improve care for patients with OA through an evidence-based, comprehensive and sustainable care model. Learn more.

Increasing Participation of Underrepresented in Lupus Clinical Trials

January 9, 2022

Saira Sheikh, MD, the Linda Coley Sewell Distinguished Professor of Medicine in the division of rheumatology, and research associate Tessa Englund, PhD, MPH, described the barriers in lupus clinical trial enrollment and how they can be addressed to ensure equitable representation. Read the article published in Rheumatology Advisor.  

Newsworthy from the Department of Medicine, Week of October 29 – November 4

November 16, 2021

The below clickable headlines link directly to outside media outlets and feature UNC Department of Medicine faculty, starting Friday, November 4, 2021. What every parent should know about Halloween safety | Four 2 Five – Dr. Emily Sickbert-Bennett (MSN.com) Food Allergy Families Seek Out Hard-to-Find Immunotherapy – Dr. Edwin Kim (WebMD) Pandemic-related drinking causing spike in … Continued

Penicillin Allergy Assessments Expand to Inpatient Areas

October 1, 2021

Imagine: You have a patient with a penicillin allergy documented in their chart. Typically, you would prescribe amoxicillin for their infection, but that is not an option because it is a penicillin-class antibiotic. Instead, you prescribe a broader-spectrum antibiotic–not your first choice except for the allergy. But, what if you learned that it is not … Continued

The OA Action Alliance, Arthritis Foundation, and CDC Release ‘Action Briefs’ Focused on Osteoarthritis

September 14, 2021

Newly released Action Briefs now make it easier for employers, insurers, healthcare systems, policy makers, and leaders in other organizations to take specific, practical actions to support their constituents with osteoarthritis. The Osteoarthritis Action Alliance (OAAA), partnering with the Centers for Disease Control and Prevention (CDC) and the Arthritis Foundation, issued A National Public Health … Continued

The Osteoarthritis Action Alliance Receives 5 Years of CDC Funding to Advance National Osteoarthritis Public Health Initiatives

August 19, 2021

Thanks to additional support from the CDC, the Osteoarthritis Action Alliance is actively addressing the devastating impact of osteoarthritis on adults and communities through strategic leveraging of partnerships, collaborations, and the resources of its 140+ member organizations. “This is a crucial time, because osteoarthritis (OA) is a leading cause of disability and work limitations among … Continued